Tension-type Headache
📧 Sign up to get email alerts when something new happens for Tension-type Headache.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-06-16FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic combination of butalbital, acetaminophen and caffeine manufactured by Granules Pharm…
-
FDA approval · 2014-04-09FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved a supplemental application for Butalbital and Acetaminophen tablets by Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Immune-Pineal Axis Function in Chronic Tension-Type Headache [Phase 2, Phase 3]
The trial investigating immune-pineal axis function in chronic tension-type headache has completed Phase 2 and Phase 3.
-
FDA approval · 2013-10-18FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for the generic combination drug butalbital, acetaminophen and caffeine manufactured by Strides Phar…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Metoclopramide Versus Ketorolac for Tension-type Headache [Phase 4]
A Phase 4 clinical trial comparing metoclopramide and ketorolac for tension-type headache has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Comparing Naproxen to Sumatriptan for Emergency Headache Patients [Phase 4]
Phase 4 trial comparing naproxen to sumatriptan for acute emergency headaches has completed and results were posted.
-
FDA approval · 2012-09-13FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Original Application (Lannett Company, Inc.)
FDA approved a generic product from Lannett Company for the combination of butalbital, acetaminophen, and caffeine.
-
FDA approval · 2012-07-19FDA Approved: FIORICET WITH CODEINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Fioricet with Codeine (butalbital/acetaminophen/caffeine with codeine phosphate) from Actavis Ph…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Effectiveness of the Treatment of Tension-type Headache With Manual and Manipulative Therapy [NA]
This completed clinical trial evaluated the effectiveness of manual and manipulative therapy for tension-type headache.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Treatment of Tension-type Headache With Articulatory and Suboccipital Soft Tissue Therapy [NA]
This clinical trial update notes that the study evaluating articulatory and suboccipital soft tissue therapy for tension-type headache has c…
-
CLINICAL_TRIALS research · 2012-01-13Clinical Trial Update: Chiropractic and Acupressure for Headaches [Phase 2, Phase 3]
This clinical trial update reports ongoing Phase 2 and Phase 3 studies evaluating chiropractic care and acupressure for headaches, including…
-
FDA approval · 2011-08-23FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' butalbital and acetaminophen tablets as a generic product (ANDA 090956) for relief of tension-type h…
-
FDA approval · 2011-06-23FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the generic combination product butalbital, acetaminophen, and caffeine (Actavis) under an ANDA.
-
FDA label_change · 2011-06-23FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (Actavis Pharma, Inc.)
FDA documents a supplemental application for the generic combination butalbital, acetaminophen, and caffeine, indicating changes to the prod…
-
FDA approval · 2011-06-22FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for the analgesic combination butalbital/acetaminophen/caffeine from Chartwell RX, LLC.
-
FDA approval · 2011-06-22FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Mayne Pharma)
FDA approves the supplemental application for the generic combination of butalbital, acetaminophen and caffeine manufactured by Mayne Pharma…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Large Population [Phase 3]
A Phase 3 clinical trial evaluates a cognitive and physical intervention to reduce head and neck pain. The study includes participants with …
-
FDA approval · 2009-11-16FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for the generic fixed-dose combination of butalbital, acetaminophen, and caffeine (Actavis) for relief…
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community [Phase 3]
Phase 3 trial evaluating a cognitive and physical intervention to reduce head and neck pain among workers, including migraine and tension-ty…
-
FDA approval · 2009-07-06FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Genus Lifesciences Inc.)
The FDA granted approval of Genus Lifesciences Inc.'s supplemental application for the combination drug Butalbital, Acetaminophen and Caffei…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Prophylactic Effect of Memantine in Chronic Tension-Type Headache [Phase 3]
A Phase 3 trial evaluating memantine as a preventive treatment for chronic tension-type headache has completed. The update notes the complet…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Psychological Assessment and Treatment of Chronic Benign Headache [NA]
A VA-sponsored clinical trial evaluating psychological assessment and treatment approaches for chronic benign headache has completed. The st…
-
FDA approval · 2008-12-01FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc. for a generic version of Butalbital, Acetaminophen and Caffeine (Butalbital/Acetaminophen/Caffein…
-
FDA approval · 2008-03-20FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved a supplemental application for the combination product butalbital, aspirin, and caffeine from Westminster Pharmaceuticals, LLC.